Dr. Bettencourt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
29 Ridgewood Rd
Springfield, VT 05156Phone+1 802-886-3556Fax+1 802-886-2535
Education & Training
National Capital ConsortiumResidency, Urology, 1993 - 1998
Tripler Army Medical CenterInternship, Transitional Year, 1990 - 1991
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1990
Certifications & Licensure
NH State Medical License 2004 - 2026
VT State Medical License 2004 - 2024
VA State Medical License 2012 - 2022
CT State Medical License 2002 - 2005
MD State Medical License 1991 - 1998- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 121 citationsKi-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.Marie-Claude Bettencourt, John J. Bauer, Isabell A. Sesterhenn, F.K. Mostofi, David G. McLeod
The Journal of Urology. 1996-09-01 - 102 citationsProtein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancerJudd W. Moul, Marie-Claude Bettencourt, Isabell A. Sesterhenn, F.K. Mostofi, David G. McLeod
Surgery. 1996-08-01 - 141 citationsCD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMYMarie-Claude Bettencourt, John J. Bauer, Isabella A. Sesterhenn, Roger R. Connelly, Judd W. Moul
The Journal of Urology. 1998-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
